Завершено
Фаза II
Atacicept 75 milligram (mg); Atacicept 150 mg; Placebo · EMD Serono
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)